Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Sweet

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Psychopharmacology|August 1, 1997
Lack of interaction of monoamine oxidase inhibitors and epinephrine in an older patientD S Thompson, R A Sweet, K Marzula, et al.
Molecular Psychiatry|May 13, 2003
Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotypeR A Sweet, V L Nimgaonkar, B Devlin, et al.
Mayo Clinic Proceedings|March 1, 1978
Fluorescent thyroid scanning. A method based on stable iodine measurementsH W Wahner, R A Sweet, W M McConahey, et al.
Annals of Internal Medicine|August 1, 1980
Vitamin D metabolite levels in oncogenic osteomalaciaR A Sweet, J L Males, A J Hamstra, et al.
The American Journal of Psychiatry|January 1, 1992
Relation of age to prevalence of tardive dyskinesiaR A Sweet, B H Mulsant, A H Rifai, et al.
Cellular Signalling|July 25, 2022
Trio and Kalirin as unique enactors of Rho/Rac spatiotemporal precisionM J Grubisha, R A DeGiosio, Z P Wills, et al.
Journal of Geriatric Psychiatry and Neurology|July 1, 1992
Dyskinesia and neuroleptic exposure in elderly psychiatric inpatientsR A Sweet, B H Mulsant, A H Rifai, et al.
Minnesota Medicine|December 1, 1976
Chemodectoma with multiple skeletal metastasis and anemiaR A Sweet, J F Fairbairn, J W Joyce, et al.
Journal of Clinical Psychopharmacology|October 1, 1991
Potential interactions between monoamine oxidase inhibitors and prescribed dietary supplementsR A Sweet, M R Liebowitz, C S Holt, et al.
Neuroscience|December 13, 2005
Regional specificity of chandelier neuron axon terminal alterations in schizophreniaG T Konopaske, R A Sweet, Q Wu, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Psychopharmacology|August 1, 1997
Lack of interaction of monoamine oxidase inhibitors and epinephrine in an older patientD S Thompson, R A Sweet, K Marzula, et al.
Molecular Psychiatry|May 13, 2003
Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotypeR A Sweet, V L Nimgaonkar, B Devlin, et al.
Mayo Clinic Proceedings|March 1, 1978
Fluorescent thyroid scanning. A method based on stable iodine measurementsH W Wahner, R A Sweet, W M McConahey, et al.
Annals of Internal Medicine|August 1, 1980
Vitamin D metabolite levels in oncogenic osteomalaciaR A Sweet, J L Males, A J Hamstra, et al.
The American Journal of Psychiatry|January 1, 1992
Relation of age to prevalence of tardive dyskinesiaR A Sweet, B H Mulsant, A H Rifai, et al.
Cellular Signalling|July 25, 2022
Trio and Kalirin as unique enactors of Rho/Rac spatiotemporal precisionM J Grubisha, R A DeGiosio, Z P Wills, et al.
Journal of Geriatric Psychiatry and Neurology|July 1, 1992
Dyskinesia and neuroleptic exposure in elderly psychiatric inpatientsR A Sweet, B H Mulsant, A H Rifai, et al.
Minnesota Medicine|December 1, 1976
Chemodectoma with multiple skeletal metastasis and anemiaR A Sweet, J F Fairbairn, J W Joyce, et al.
Journal of Clinical Psychopharmacology|October 1, 1991
Potential interactions between monoamine oxidase inhibitors and prescribed dietary supplementsR A Sweet, M R Liebowitz, C S Holt, et al.
Neuroscience|December 13, 2005
Regional specificity of chandelier neuron axon terminal alterations in schizophreniaG T Konopaske, R A Sweet, Q Wu, et al.
Pageof 8